No Data
US Stock MarketDetailed Quotes
MBOT Microbot Medical
Watchlist
1.290
+0.030+2.38% Close 12/01 16:00 ET
1.350+0.060+4.65%
Post 17:51 ET
1.300High1.245Low66.48KVolume
1.250Open1.260Pre Close84.45KTurnover0.61%Turnover RatioLossP/E (TTM)15.10MMarket Cap4.65052wk HighLossP/E (Static)11.71MShares1.00052wk Low2.05P/B14.00MFloat Cap323999.370Historical High--Dividend TTM10.85MShs Float1.000Historical Low--Div YieldTTM4.37%Amplitude1.270Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Microbot Medical Company
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
News
Microbot Medical Files $75 Million Shelf
Microbot Medical (MBOT) on Friday filed a registration statement for the potential sale of up to $75 million of its securities from time to time. The filing covers the potential sale of the company's
Microbot Medical Inc Files For Mixed Shelf Of Upto $75M
Microbot Medical Inc Files For Mixed Shelf Of Upto $75M
Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process
BRAINTREE, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ:MBOT), developer of the innovative LIBERTY Robotic Surgical System, today announces it had successfully completed the
Comments
Dr. Diaz-Cartelle's appointment signifies Microbot Medical's transition to clinical and regulatory phases. His proficiency in clinical trial management will be crucial in Microbot's journey to FDA clearance and pioneering robotic surgery standards.
Press Release: Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as Its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities
$Microbot Medical(MBOT.US$ Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process
1
News
$Microbot Medical(MBOT.US$ Microbot Medical Granted A Registered Trademark From The U.S. Patent And Trademark Office For "One & Done" Given To The Feature Of The Liberty Robotic Surgical System Which Is Being Developed To Integrate Guidewires, Microcatheters And Other Instruments
Benzinga· 3 mins ago
Benzinga· 3 mins ago
1
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--